Dong Yan

8PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Single Cell and Machine Learning-Based Analysis of Lysosome Mediated Cell Death Reveals Novel Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer.

|Dec 04, 2025
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer.

Noboru Yamamoto, Dong Yan, Vinod Ganju

|Nov 10, 2025
The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma.

Yingying Tong, Xin Liu, Qian Liu

|Feb 03, 2025
Correction: Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.

Chao An, Ran Wei, Wendao Liu

|Jul 06, 2024
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.

Chao An, Ran Wei, Wendao Liu

|May 27, 2024
Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression.

Yingying Tong, Xin Liu, Lihui Wu

Pageof 2

Frequent Collaborators

3 joint publications

Yingying Tong

2 joint publications

Peihong Wu

1 joint publications

Dong Guo

1 joint publications

Jing Wang